Coronavirus Vaccine: Bangavax and two other vaccines to meet human trial conditions
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
July 07, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, JULY 07, 2025
Bangavax and two other vaccines to meet human trial conditions

Covid-19 in Bangladesh

TBS Report
16 June, 2021, 02:15 pm
Last modified: 16 June, 2021, 08:46 pm

Related News

  • Bangavax gets DGDA nod for human trials
  • Globe Biotech publishes Bangavax results of tests on monkeys
  • Indian Covaxin to be permitted for trial in Bangladesh
  • TBS Today: Bangavax trials face scientific and ethical concerns
  • NZ regulator approves Pfizer vaccine for 12-15 year olds

Bangavax and two other vaccines to meet human trial conditions

Globe Biotech and two Indian and Chinese drugmakers must submit documents on the effectiveness and side effects of the vaccines on monkeys

TBS Report
16 June, 2021, 02:15 pm
Last modified: 16 June, 2021, 08:46 pm
Logo of Globe Biotech Limited. Picture: Collected
Logo of Globe Biotech Limited. Picture: Collected

The Bangladesh Medical Research Council (BMRC) has set conditions for the human trial of three more coronavirus vaccines, including local drugmaker Globe Biotech's Bangavax, and two others from China and India respectively.

Before "human trials", the institutes will have to fulfil all conditions as per BMRC rules.

The decision was made at a meeting of the National Research Ethics Committee of the BMRC on Wednesday morning.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"We have decided in principle to approve the three vaccines. But they must meet certain conditions," BMRC Director, Professor Dr Ruhul Amin, told journalists after the meeting.

"All documents on the effectiveness and side effects of these vaccines on monkeys or chimpanzees must be submitted to the BMRC prior to Phase-1 trials. The issue of safety in human use will be seriously considered. If these rules are followed, we will definitely approve."

In addition to Bangavax, it has been decided in principle to approve the applications of Bharat Biotech and the Vero cell vaccine by the Institute of Medical Biology, Chinese Academy of Medical Sciences.

Two icddr,b scientists sought approval for the Chinese and Indian vaccines, and Globe Biotech for Bangavax.

Dr Ruhul Amin said, "It is not that the Globe vaccine has received approval for a clinical trial. But we are positive, even though several issues have been raised, including safety issues."

He said the three companies that have applied for first and second phase clinical trials will be informed of the Bangladesh Medical Research Council's (BMRC) decision.

"If necessary, the Contract Research Organisations (CROs) of the three companies can be called at any time to know the current status of the institutes," he added.

On 28 December, Globe Biotech, a Bangladeshi biotech firm, got approval from the Directorate General of Drug Administration (DGDA) to produce Covid-19 vaccine candidate Bangavax to carry out clinical trials.

On 16 January it submitted its trial protocol to the BMRC for the clinical trials of its Covid-19 vaccine, Bangavax.

Earlier, the company on 5 October 2020, noted that vaccine trials on rabbits and mice had shown "very promising results."

Bangladesh has so far approved the emergency use of six vaccines – Oxford-AstraZeneca, Sinopharm of China, Sputnik-V of Russia, Pfizer-BioNTech, CronaVac of China, and Johnson & Johnson.

Bangladesh / Top News

BMRC / conditonally / approves / human trial / Bangavax

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • US President Donald Trump speaks to the press before boarding Air Force One as he departs for Iowa, at Joint Base Andrews, Maryland, US, July 3, 2025. Photo: REUTERS/Nathan Howard
    Trump and US commerce secretary say tariffs are delayed until 1 August
  • We are forced to disregard many issues but trying to reach consensus wherever possible: Ali Riaz
    We are forced to disregard many issues but trying to reach consensus wherever possible: Ali Riaz
  • BNP Secretary General Mirza Fakhrul Islam Alamgir. Photo: TBS
    BNP optimistic that democracy will be established in Bangladesh thru next election: Fakhrul

MOST VIEWED

  • Ships and shipping containers are pictured at the port of Long Beach in Long Beach, California, US, 30 January 2019. Photo: REUTERS
    Bangladesh may offer zero-duty on US goods to get reciprocal tariff relief
  • A quieter scene at Dhaka University’s central library on 29 June, with seats still unfilled—unlike earlier this year, when the space was overwhelmed by crowds of job aspirants preparing for competitive exams. Photo: Tahmidul Alam Jaeef
    No more long queues at DU Central Library. What changed?
  • Labour unrests disrupt CEPZ operations as financial crisis hits factories
    Labour unrests disrupt CEPZ operations as financial crisis hits factories
  • Infographic: TBS
    Japanese loan rate hits record 2%, still remains cheaper than others
  • Students during a protest procession seeking end of discrimination in engineering jobs in Chattogram on 5 July 2025. Photo: TBS
    Ctg students protest against discrimination in engineering profession
  • Benapole port: Revenue exceeds target by Tk316cr while imports decline
    Benapole port: Revenue exceeds target by Tk316cr while imports decline

Related News

  • Bangavax gets DGDA nod for human trials
  • Globe Biotech publishes Bangavax results of tests on monkeys
  • Indian Covaxin to be permitted for trial in Bangladesh
  • TBS Today: Bangavax trials face scientific and ethical concerns
  • NZ regulator approves Pfizer vaccine for 12-15 year olds

Features

The Mitsubishi Xpander is built with families in mind, ready to handle the daily carpool, grocery runs, weekend getaways, and everything in between. PHOTO: Akif Hamid

Now made-in-Bangladesh: 2025 Mitsubishi Xpander

13h | Wheels
Students of different institutions protest demanding the reinstatement of the 2018 circular cancelling quotas in recruitment in government jobs. Photo: Mehedi Hasan

5 July 2024: Students announce class boycott amid growing protests

2d | Panorama
Contrary to long-held assumptions, Gen Z isn’t politically clueless — they understand both local and global politics well. Photo: TBS

A misreading of Gen Z’s ‘political disconnect’ set the stage for Hasina’s ouster

2d | Panorama
Graphics: TBS

How courier failures are undermining Bangladesh’s online perishables trade

2d | Panorama

More Videos from TBS

No war crimes committed in July: Sheikh Hasina's lawyer

No war crimes committed in July: Sheikh Hasina's lawyer

34m | TBS Today
Israel and Hamas ceasefire talks end without agreement

Israel and Hamas ceasefire talks end without agreement

1h | TBS World
Israel attacks three ports and a power plant in Yemen

Israel attacks three ports and a power plant in Yemen

3h | TBS World
Karbala; one of the saddest and most tragic events in Islamic history

Karbala; one of the saddest and most tragic events in Islamic history

15h | TBS Stories
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net